HEADER TRANSCRIPTION 02-OCT-18 6MNL TITLE NMR SOLUTION STRUCTURES OF SECOND BROMODOMAIN OF BRD4 WITH FOXO3A TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOXO3A PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: BROMO 2 DOMAIN, RESIDUES 333-460; COMPND 9 SYNONYM: PROTEIN HUNK1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 GENE: BRD4, HUNK1; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRD4, CDK6, AKT, LUMINAL BREAST CANCER, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.ZENG,M.-M.ZHOU REVDAT 4 15-NOV-23 6MNL 1 ATOM REVDAT 3 14-JUN-23 6MNL 1 REMARK REVDAT 2 19-DEC-18 6MNL 1 JRNL REVDAT 1 31-OCT-18 6MNL 0 JRNL AUTH J.LIU,Z.DUAN,W.GUO,L.ZENG,Y.WU,Y.CHEN,F.TAI,Y.WANG,Y.LIN, JRNL AUTH 2 Q.ZHANG,Y.HE,J.DENG,R.L.STEWART,C.WANG,P.C.LIN,S.GHAFFARI, JRNL AUTH 3 B.M.EVERS,S.LIU,M.M.ZHOU,B.P.ZHOU,J.SHI JRNL TITL TARGETING THE BRD4/FOXO3A/CDK6 AXIS SENSITIZES AKT JRNL TITL 2 INHIBITION IN LUMINAL BREAST CANCER. JRNL REF NAT COMMUN V. 9 5200 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30518851 JRNL DOI 10.1038/S41467-018-07258-Y REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.3, CNS REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), BRUNGER, REMARK 3 ADAMS, CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MNL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237263. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 100 MM SODIUM CHLORIDE, 10 MM REMARK 210 SODIUM PHOSPHATE, 2 MM [U-100% REMARK 210 2H] DTT, 95% H2O/5% D2O; 100 MM REMARK 210 SODIUM CHLORIDE, 10 MM SODIUM REMARK 210 PHOSPHATE, 2 MM [U-100% 2H] DTT, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D 1H-15N NOESY; 3D REMARK 210 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 13C NOESY AROMATIC; 3D FILTERED REMARK 210 1H-13C NOESY ALIPHATIC; 3D REMARK 210 FILTERED 1H-13C NOESY AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 500 MHZ; 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW 5, PROCHECKNMR, NMRPIPE, REMARK 210 TOPSPIN, CNS REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 11 -71.91 -77.26 REMARK 500 1 ARG A 13 95.65 -170.79 REMARK 500 1 ARG A 14 94.99 -69.51 REMARK 500 1 ALA A 15 -55.25 -157.78 REMARK 500 1 GLN B 339 32.31 -87.59 REMARK 500 1 GLN B 340 -68.86 65.40 REMARK 500 1 GLU B 345 -83.45 64.98 REMARK 500 1 LYS B 346 -70.34 -143.20 REMARK 500 1 SER B 347 75.24 -157.87 REMARK 500 1 ASP B 389 66.82 -163.62 REMARK 500 1 ASP B 414 -174.01 -176.92 REMARK 500 1 LYS B 456 40.75 -83.97 REMARK 500 2 ALY A 9 114.60 75.39 REMARK 500 2 ALA A 15 -26.40 -160.94 REMARK 500 2 HIS B 341 85.32 -156.33 REMARK 500 2 PRO B 344 85.40 -63.48 REMARK 500 2 GLU B 345 -46.32 174.80 REMARK 500 2 LYS B 346 -63.80 -168.21 REMARK 500 2 SER B 347 -33.59 -176.85 REMARK 500 2 SER B 348 -72.85 69.44 REMARK 500 2 HIS B 388 -40.51 72.17 REMARK 500 2 ASP B 389 65.61 -113.96 REMARK 500 2 LYS B 456 41.03 -81.47 REMARK 500 3 ARG A 12 81.06 62.74 REMARK 500 3 ALA A 15 -73.65 66.77 REMARK 500 3 GLU B 345 -152.71 56.91 REMARK 500 3 SER B 347 -53.19 -168.64 REMARK 500 3 SER B 348 -67.42 69.45 REMARK 500 3 ASP B 389 74.58 -156.03 REMARK 500 4 PRO A 2 38.56 -84.87 REMARK 500 4 ARG A 13 -77.97 -102.10 REMARK 500 4 ARG A 14 -101.69 -115.39 REMARK 500 4 ALA A 15 -91.71 54.57 REMARK 500 4 ASP B 337 -80.61 -99.40 REMARK 500 4 PRO B 344 -152.79 -66.06 REMARK 500 4 LYS B 456 41.78 -79.60 REMARK 500 5 PRO B 336 84.89 -66.94 REMARK 500 5 PRO B 344 95.58 -64.38 REMARK 500 5 GLU B 345 -59.91 71.25 REMARK 500 5 SER B 348 -67.42 68.57 REMARK 500 5 VAL B 380 115.04 -36.41 REMARK 500 5 GLU B 438 -73.05 -51.28 REMARK 500 5 LYS B 456 -84.56 -67.84 REMARK 500 5 MET B 457 80.70 41.43 REMARK 500 6 PRO A 2 77.55 -67.85 REMARK 500 6 ASP A 3 -76.90 65.46 REMARK 500 6 PRO A 11 -85.44 -69.70 REMARK 500 6 ARG A 13 -69.18 -125.40 REMARK 500 6 GLN B 339 -61.69 -175.94 REMARK 500 6 GLU B 345 -63.89 72.80 REMARK 500 REMARK 500 THIS ENTRY HAS 160 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30373 RELATED DB: BMRB DBREF 6MNL A 1 16 PDB 6MNL 6MNL 1 16 DBREF 6MNL B 333 460 UNP O60885 BRD4_HUMAN 333 460 SEQRES 1 A 16 ASN PRO ASP GLY GLY ALY SER GLY ALY ALA PRO ARG ARG SEQRES 2 A 16 ARG ALA VAL SEQRES 1 B 128 LYS ASP VAL PRO ASP SER GLN GLN HIS PRO ALA PRO GLU SEQRES 2 B 128 LYS SER SER LYS VAL SER GLU GLN LEU LYS CYS CYS SER SEQRES 3 B 128 GLY ILE LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA SEQRES 4 B 128 TYR ALA TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA SEQRES 5 B 128 LEU GLY LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO SEQRES 6 B 128 MET ASP MET SER THR ILE LYS SER LYS LEU GLU ALA ARG SEQRES 7 B 128 GLU TYR ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG SEQRES 8 B 128 LEU MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP SEQRES 9 B 128 HIS GLU VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL SEQRES 10 B 128 PHE GLU MET ARG PHE ALA LYS MET PRO ASP GLU HET ALY A 6 26 HET ALY A 9 26 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 1 ALY 2(C8 H16 N2 O3) HELIX 1 AA1 SER B 347 PHE B 365 1 19 HELIX 2 AA2 ALA B 373 LYS B 378 1 6 HELIX 3 AA3 ASP B 381 GLY B 386 1 6 HELIX 4 AA4 ASP B 399 ARG B 410 1 12 HELIX 5 AA5 ASP B 414 ASN B 433 1 20 HELIX 6 AA6 HIS B 437 ALA B 455 1 19 LINK C GLY A 5 N ALY A 6 1555 1555 1.32 LINK C ALY A 6 N SER A 7 1555 1555 1.32 LINK C GLY A 8 N ALY A 9 1555 1555 1.33 LINK C ALY A 9 N ALA A 10 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1